Allworth Financial’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Other funds holding IHE
IWS
Allworth Financial's IHE Position: Q2 2026 in Review
Allworth Financial reduced its iShares US Pharmaceuticals ETF (IHE) stake by 6.2% in Q2 2026, selling an estimated $8.92K and leaving 1,490 shares worth $148K. The position accounts for ﹤0.01% of the portfolio, ranked #1700.
Allworth Financial first reported a position in IHE in Q1 2021 and has held it in 22 quarters since. 209 funds tracked by Wall St. Rank hold IHE as of Q2 2026.
- Allworth Financial held 1,490 shares of iShares US Pharmaceuticals ETF worth $148K as of Q2 2026.
- Allworth Financial sold 99 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $8.92K.
- iShares US Pharmaceuticals ETF made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #1700 holding.
- Allworth Financial first reported a position in iShares US Pharmaceuticals ETF in Q1 2021 and has held it in 22 quarters since.
- 209 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.
Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.